<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell J</journal-id><journal-id journal-id-type="iso-abbrev">Cell J</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>Cell Journal (Yakhteh)</journal-title></journal-title-group><issn pub-type="ppub">2228-5806</issn><issn pub-type="epub">2228-5814</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24027665</article-id><article-id pub-id-type="pmc">3769606</article-id><article-id pub-id-type="other">Cell-J-15-238</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group><subject>Immunology</subject><subject>Parasitology</subject></subj-group></subj-group></article-categories><title-group><article-title>Modification and Evaluation of Avidity IgG Testing for
Differentiating of Toxoplasma gondii Infection in Early
Stage of Pregnancy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bonyadi</surname><given-names>Mohammad Reza</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Bastani</surname><given-names>Parvin</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><aff id="A1"><label>1</label>Infection Disease and Tropical Research Center, Immunology Research Center, Faculty of Medicine, Applied Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran</aff><aff id="A2"><label>2</label>Women’s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</aff></contrib-group><author-notes><corresp id="cor1">
* Corresponding Address: <addr-line>P.O.Box: 51666-1476</addr-line><addr-line>Infection Disease and Tropical Research Center</addr-line><addr-line>Immunology Research Center</addr-line><addr-line>Faculty of Medicine</addr-line><addr-line>Applied Research Center</addr-line><institution>Tabriz University of Medical Sciences</institution><addr-line>Tabriz</addr-line><country>Iran</country>
Email: <email>bonyadir@tbzmed.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Autumn</season><year>2013</year></pub-date><pub-date pub-type="epub"><day>24</day><month>8</month><year>2013</year></pub-date><volume>15</volume><issue>3</issue><fpage>238</fpage><lpage>243</lpage><history><date date-type="received"><day>26</day><month>8</month><year>2012</year></date><date date-type="accepted"><day>1</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3468" xml_f="3478" txt_i="11" txt_f="21">Objective:</offsets></title><p><offsets xml_i="3489" xml_f="4029" txt_i="22" txt_f="562">Toxoplasma gondii infection, an intracellular parasite, is often asymptomatic or is
caused by different clinical diseases without being detected. Evaluation of IgG, IgA, and IgM
in order to diagnose the pending Toxoplasmosis may confront some problems. Several researches has showned that Toxo IgG avidity can be useful in the recent active Toxoplasmosis.
In current study, modification and importance of improved Toxoplasma Avidity IgG testing has
been evlauated for differentiating Toxoplasma gondii infection in early stage of pregnancy.</offsets></p></sec><sec><title><offsets xml_i="4051" xml_f="4073" txt_i="564" txt_f="586">Materials and Methods:</offsets></title><p><offsets xml_i="4084" xml_f="4468" txt_i="587" txt_f="971">This experimental study included 300 pregnant women with risk
of Toxoplasmosis in their initial months of pregnancy. We randomly divided 300 serum
samples into A group (n=60) with high avidity and B group (n=40) with borderline avidity. The samples with Toxo IgG levels were classified to four subgroups. IgG avidity was
evaluated by enzyme-linked immunosorbent assay (ELISA) method. </offsets></p></sec><sec><title><offsets xml_i="4490" xml_f="4498" txt_i="973" txt_f="981">Results:</offsets></title><p><offsets xml_i="4509" xml_f="4979" txt_i="982" txt_f="1452">The mean absorbance of 100 samples in two groups was calculated, and then,
two dilutaion curves with plotted absorbance against dilution were drawn for each serum
sample. The results of this study showed that in groups with different concentrations of
toxo IgG, appropriate dilution of serum is suitable for testing of Avidity. Our findings
revealed the subgroups of 1, 2, 3, and 4 with serum dilutios of 1/3 , 1/6, 1/9, and 1/18
respectively, had real and good avidity.</offsets></p></sec><sec><title><offsets xml_i="5001" xml_f="5012" txt_i="1454" txt_f="1465">Conclusion:</offsets></title><p><offsets xml_i="5023" xml_f="5365" txt_i="1466" txt_f="1808">: One of the issues affectig the results of avidity is high concenteration of Toxo
IgG in serum sample. As shown in this study, the best points of dilution for well avidity in
both high and borderline avidities are marked with arrows in figures 1-8. This study confirmed that improved methods of measuring Toxo Avidity IgG are very important.</offsets></p></sec></abstract><kwd-group><kwd>Toxoplasmosis</kwd><kwd>Pregnancy</kwd><kwd>ELISA</kwd><kwd>IgG</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Bonyadi MR, Bastani P. Modification and evaluation of avidity IgG testing for differentiating of toxoplasma
gondii infection in early stage of pregnancy. Cell J. 2013; 15(3): 238-243.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title><offsets xml_i="5829" xml_f="5841" txt_i="1817" txt_f="1829">Introduction</offsets></title><p><offsets xml_i="5852" xml_f="6204" txt_i="1830" txt_f="2182">Toxoplasma gondii infection, an intracellular parasite, is often asymptomatic or causeed by different
clinical diseases without being detected. However,
parasite may be transmitted to the fetus after pregnant
women are infected with the Toxoplasma gondii, so
the fetus may be aborted or affected with severe neurological impairment and corioretinitis (</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="6235" xml_f="6236" txt_i="2182" txt_f="2183">1</offsets></xref><offsets xml_i="6243" xml_f="6244" txt_i="2183" txt_f="2184">-</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="6275" xml_f="6276" txt_i="2184" txt_f="2185">3</offsets></xref><offsets xml_i="6283" xml_f="6285" txt_i="2185" txt_f="2187">).</offsets></p><p><offsets xml_i="6292" xml_f="7162" txt_i="2188" txt_f="3058">Evaluation of IgG, IgA, and IgM in order to diagnose the pending Toxoplasmosis may confront some
problems. Serum IgG is valuable when the first test
is negative, but the second one, after a few weeks,
is positive. On the other hand, serum IgM remains
positive for several months. Also, Rheumatoid factor
(RF) causes false positive IgM. When the pregnant
woman has high Toxo IgG and positive IgM, different
tests must be perform for clarifying between a new
infection or an old infection of Toxoplasma. In the
cases with high levels of positive IgG and IgM before pregnancy, the embryo would be protected against
Toxoplasma gondii infection, but in those cases with
positive test result after pregnancy, the embryo is subjected to a serious risk. Initially, IgG avidity test has
been applied through denaturalization technique for
diagnosis of the congenital Rubellosis (</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="7193" xml_f="7194" txt_i="3058" txt_f="3059">4</offsets></xref><offsets xml_i="7201" xml_f="7203" txt_i="3059" txt_f="3061">, </offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="7234" xml_f="7235" txt_i="3061" txt_f="3062">5</offsets></xref><offsets xml_i="7242" xml_f="7244" txt_i="3062" txt_f="3064">).</offsets></p><p><offsets xml_i="7251" xml_f="7560" txt_i="3065" txt_f="3374">In 1989, Hedman introduced a new method, named
avidity test, which was based on the tendency of connecting immunoglobulin to Toxoplasma gondii polyvalent antigens using high density of urea to differentiate the high tendency of immunoglobulin. This test
is recently used for detecting Toxoplasma IgG avidity
(</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="7591" xml_f="7592" txt_i="3374" txt_f="3375">6</offsets></xref><offsets xml_i="7599" xml_f="7903" txt_i="3375" txt_f="3679">). IgG avidity in initial steps of Toxoplasmosis infection is low, but the avidity of IgG from an old infection is very high. According to the recent researches, when the avidity is lower than 40%, it indicats
initial infection or active steps, but when it is higher
than 50%, it shows an old infection (</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="7934" xml_f="7935" txt_i="3679" txt_f="3680">7</offsets></xref><offsets xml_i="7942" xml_f="8027" txt_i="3680" txt_f="3765">). In other studies, avidity titers lower than 30% has been reported as
low avidity (</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="8058" xml_f="8059" txt_i="3765" txt_f="3766">8</offsets></xref><offsets xml_i="8066" xml_f="8068" txt_i="3766" txt_f="3768">, </offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="8099" xml_f="8100" txt_i="3768" txt_f="3769">9</offsets></xref><offsets xml_i="8107" xml_f="8290" txt_i="3769" txt_f="3952">). Increased titer of Toxoplasma IgG
can also be used in recognition of recent Toxoplasmosis infection, but its monitoring requires a longer time
that might be harmful to the embryo (</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8322" xml_f="8324" txt_i="3952" txt_f="3954">10</offsets></xref><offsets xml_i="8331" xml_f="8333" txt_i="3954" txt_f="3956">, </offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="8365" xml_f="8367" txt_i="3956" txt_f="3958">11</offsets></xref><offsets xml_i="8374" xml_f="8376" txt_i="3958" txt_f="3960">).</offsets></p><p><offsets xml_i="8383" xml_f="8490" txt_i="3961" txt_f="4068">Several researches have been shown that Toxo IgG
avidity can be useful in the recent active Toxoplasmosis (</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="8521" xml_f="8522" txt_i="4068" txt_f="4069">7</offsets></xref><offsets xml_i="8529" xml_f="8531" txt_i="4069" txt_f="4071">- </offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8563" xml_f="8565" txt_i="4071" txt_f="4073">10</offsets></xref><offsets xml_i="8572" xml_f="8706" txt_i="4073" txt_f="4207">). The timely diagnosis and treatment
of Toxoplasmosis during pregnancy may protect the
embryo from infection and consequent damages (</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="8738" xml_f="8740" txt_i="4207" txt_f="4209">12</offsets></xref><offsets xml_i="8747" xml_f="8961" txt_i="4209" txt_f="4423">).
Nowadays, regardless of high concentration of serum
IgG antibodies against Toxoplasma gondii in avidity
tests with commercial kits, a single sample of patient’s
blood with high concentrations of urea is tested (</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="8992" xml_f="8993" txt_i="4423" txt_f="4424">4</offsets></xref><offsets xml_i="9000" xml_f="9002" txt_i="4424" txt_f="4426">).</offsets></p><p><offsets xml_i="9009" xml_f="9491" txt_i="4427" txt_f="4909">It seems that interference of high serum levels of
IgG against Toxoplasma test results causes the negative outcomes. Our pilot research study showed both
IgG Toxo concentration of 100 u /mL to 600 u /mL
rise, the test problem is that it can have false negative
results (Percent of avidity remains high). Therefore, if
patient’s serum is diluted to different ratios before testing, appropriate dilution of the serum antibodies will
be implemented and better results will be obtained.</offsets></p><p><offsets xml_i="9498" xml_f="9791" txt_i="4910" txt_f="5203">In a comparative study of four commericaly available toxo avidity kits, one in three different dilutions
of serum, while the other with single sample dilution
were used, but it did not accurately determine that
what dilutions of serum was the appropriate sample
with no false negative result (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="9823" xml_f="9825" txt_i="5203" txt_f="5205">13</offsets></xref><offsets xml_i="9832" xml_f="10022" txt_i="5205" txt_f="5395">). In current study,
modification and importance of improved Toxoplasma Avidity IgG testing has been evlauated for differentiating of Toxoplasma gondii infection in early
stage of pregnancy.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="10073" xml_f="10094" txt_i="5397" txt_f="5418">Materials and Methods</offsets></title><sec><title><offsets xml_i="10114" xml_f="10141" txt_i="5419" txt_f="5446">Study design and population</offsets></title><p><offsets xml_i="10152" xml_f="10427" txt_i="5447" txt_f="5722">
This experimental study included 300 pregnant
women in their initial months of pregnancy with
risk of Toxoplasmosis between August, 2010 and
August, 2012. We randomly divided 300 serum
samples into A group (n=60) with high avidity and
B group (n=40) with borderline avidity.</offsets></p><p><offsets xml_i="10434" xml_f="10877" txt_i="5723" txt_f="6163">The women were referred to a reference Toxo avidity laboratory (Dr. Bonyadi’s lab, Tabriz, Iran). The
result showed that both serum levels of Toxo IgG
and IgM were positive. The avidity Toxo testing in
patients was performed with single serum samples.
The samples with Toxo IgG levels were classified to
the following four subgroups: subgroup 1.100-199
Iu/ml, subgroup 2.200-299 Iu/mL, subgroup 3. 300-
399 Iu/mL, and subgroup 4.&gt;400 Iu/mL.</offsets></p></sec><sec><title><offsets xml_i="10899" xml_f="10937" txt_i="6165" txt_f="6203">Enzyme-linked immunosorbent assay test</offsets></title><p><offsets xml_i="10948" xml_f="11253" txt_i="6204" txt_f="6509">
The levels of anti-toxoplasma IgG and IgM were
measured at the beginning of pregnancy according
to manufacturer’s instruction (Vircell Microbiology
Co, Granada, Spain). The measurement of Toxo-IgG
was quantitative, but that of Toxo-IgM was conducted
through an index report by computing the cutoff point.</offsets></p></sec><sec><title><offsets xml_i="11275" xml_f="11327" txt_i="6511" txt_f="6563">Avidity test using enzyme-linked immunosorbent
assay</offsets></title><p><offsets xml_i="11338" xml_f="11992" txt_i="6564" txt_f="7218">Serial dilution from samples were prepared in the
four series, including 1/3x, 1/6x, 1/9x, and 1/18x,
which the "x" is the base dilution according to the kit
instructions (In Vircel and Acone kit: x=20, while in
Radim: x=100). For example, serial dilutions for Vircell and Acone kit are as follows: 1/60, 1/120, 1/180,
and 1/360, while those for Radim Kit are as follows:
1/300, 1/600, 1/900, and 1/1800. A total of 400 tests
were carried out according to Headmen’s method.
Headmen’s method includes urea with concentration
of 6 Mol placed in an incubation for 10 minutes, while
one sample with urea and other sample without urea
following the formula. (</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="12023" xml_f="12024" txt_i="7218" txt_f="7219">4</offsets></xref><offsets xml_i="12031" xml_f="12699" txt_i="7219" txt_f="7887">). Patient’s diluted sera were
added to micro plates coated with Toxoplasma antigen. In the second step, concentrated (8M) urea solution was added to the antigen-antibody mixture. After
washing excess antibody, labeled anti-IgG antibody
was added to the test micro plates. After 30 minute
of incubation and re-washing, substrate solution was added, and in the final step, the reaction was stopped
by adding sulfuric acid. The optical density (OD) was
measured at 450 nm against the differential wavelength of 600 nm. The avidity was calculated by the
following formula: Avidity Index (%)=(OD sample
treatment with urea-OD blank)/(OD sample treatment
without urea)×100.</offsets></p><p><offsets xml_i="12706" xml_f="12815" txt_i="7888" txt_f="7997">The average light absorption of 100 samples with
high and borderline avidity in different groups was
plotted.</offsets></p></sec><sec><title><offsets xml_i="12837" xml_f="12885" txt_i="7999" txt_f="8047">Statistical analysis and ethical considerations </offsets></title><p><offsets xml_i="12896" xml_f="13466" txt_i="8048" txt_f="8618">
Statistical analysis was performed by SPSS software package version 16.0 for windows (SPSS Inc.,
Chicago, USA). Quantitative data were presented as
mean ± standard deviation (SD), while qualitative
data were demonstrated as frequency and percent (%).
For statistical analysis, collected data were studied using descriptive statistical methods. The study protocol was approved by the Ethics Committee of Tabriz
University of Medical Sciences (TUMS), which was
in compliance with Helsinki Declaration. All patients
signed the consent in order to participate in this study</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="13513" xml_f="13520" txt_i="8621" txt_f="8628">Results</offsets></title><p><offsets xml_i="13531" xml_f="13712" txt_i="8629" txt_f="8810">The average light absorption of each subgroup
in four different serum dilutions and in two high
and borderline avidity groups were calculated. All
results were shown in figures 1-8.</offsets></p><p><offsets xml_i="13719" xml_f="13999" txt_i="8811" txt_f="9091">The results of this study showed that in the
groups with different Toxo IgG concentration,
specific dilution of serum is suitable for avidity
testing. For example in subgroups of 1-4, serum
dilutions of 1/3, 1/6, 1/9, and 1/18, respectively,
illustrate a real and perfect avidity.</offsets></p><fig id="F1" orientation="portrait" position="float"><label><offsets xml_i="14063" xml_f="14068" txt_i="9092" txt_f="9097">Fig 1</offsets></label><caption><p><offsets xml_i="14088" xml_f="14123" txt_i="9097" txt_f="9132">High avidityToxo IgG 100-199 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g01"></graphic></fig><fig id="F2" orientation="portrait" position="float"><label><offsets xml_i="14253" xml_f="14258" txt_i="9133" txt_f="9138">Fig 2</offsets></label><caption><p><offsets xml_i="14278" xml_f="14312" txt_i="9138" txt_f="9172">High avidityToxo IgG 200-299 Iu/mL</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g02"></graphic></fig><fig id="F3" orientation="portrait" position="float"><label><offsets xml_i="14442" xml_f="14447" txt_i="9173" txt_f="9178">Fig 3</offsets></label><caption><p><offsets xml_i="14467" xml_f="14501" txt_i="9178" txt_f="9212">High avidityToxo IgG 300-399 Iu/mL</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g03"></graphic></fig><fig id="F4" orientation="portrait" position="float"><label><offsets xml_i="14631" xml_f="14636" txt_i="9213" txt_f="9218">Fig 4</offsets></label><caption><p><offsets xml_i="14656" xml_f="14691" txt_i="9218" txt_f="9250">High avidityToxo IgG &gt;400 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g04"></graphic></fig><fig id="F5" orientation="portrait" position="float"><label><offsets xml_i="14821" xml_f="14826" txt_i="9251" txt_f="9256">Fig 5</offsets></label><caption><p><offsets xml_i="14846" xml_f="14888" txt_i="9256" txt_f="9298">Borderline avidity Toxo IgG 100-199 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g05"></graphic></fig><fig id="F6" orientation="portrait" position="float"><label><offsets xml_i="15018" xml_f="15023" txt_i="9299" txt_f="9304">Fig 6</offsets></label><caption><p><offsets xml_i="15043" xml_f="15084" txt_i="9304" txt_f="9345">Borderline avidityToxo IgG 200-299 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g06"></graphic></fig><fig id="F7" orientation="portrait" position="float"><label><offsets xml_i="15214" xml_f="15219" txt_i="9346" txt_f="9351">Fig 7</offsets></label><caption><p><offsets xml_i="15239" xml_f="15279" txt_i="9351" txt_f="9391">Borderline avidityToxo IgG300-399 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g07"></graphic></fig><fig id="F8" orientation="portrait" position="float"><label><offsets xml_i="15409" xml_f="15414" txt_i="9392" txt_f="9397">Fig 8</offsets></label><caption><p><offsets xml_i="15434" xml_f="15474" txt_i="9397" txt_f="9434">Borderline avidityToxo IgG&gt;400 Iu/mL.</offsets></p></caption><graphic xlink:href="Cell-J-15-238-g08"></graphic></fig></sec><sec sec-type="discussion"><title><offsets xml_i="15584" xml_f="15594" txt_i="9436" txt_f="9446">Discussion</offsets></title><p><offsets xml_i="15605" xml_f="15967" txt_i="9447" txt_f="9809">Avidity test for toxoplasmosis was described
by Hedman in 1989. Varios companies then produced commercial kits in order to routinize the
test. Almost in all kits, the avidity test is used on
a single serum sample, and if a good method is
not be selected, false toxoplasmosis results followed by low avidity value may occure during
the first months of pregnancy (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="15999" xml_f="16001" txt_i="9809" txt_f="9811">13</offsets></xref><offsets xml_i="16008" xml_f="16273" txt_i="9811" txt_f="10076">). Serological
diagnosis of toxo IgG and IgM from a single
sample can not clearly identify acute infection
from chronic one. The resaon is that IgM antibodies tend to remain for years after a primary
infection (which emerge early infection), even
with high titers (</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="16305" xml_f="16307" txt_i="10076" txt_f="10078">14</offsets></xref><offsets xml_i="16314" xml_f="16369" txt_i="10078" txt_f="10133">). Toxo IgM may be stable
from six months to 12 years (</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="16401" xml_f="16403" txt_i="10133" txt_f="10135">15</offsets></xref><offsets xml_i="16410" xml_f="16411" txt_i="10135" txt_f="10136">-</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="16443" xml_f="16445" txt_i="10136" txt_f="10138">17</offsets></xref><offsets xml_i="16452" xml_f="16797" txt_i="10138" txt_f="10483">), so applying an avidity test is the best way to differentiate
acute infection from a chronic one. If the characteristics of avidity test reduce, a challenge in
diagnosis and treatment of toxoplasmosis may
occur. Terefore, by improing avidity method at
different concentrations of 100 to 600 iu/ml, we
can elevate its sensitivity and specifity.</offsets></p><p><offsets xml_i="16804" xml_f="17028" txt_i="10484" txt_f="10708">The exact time of occurance of Toxoplasmic infection is a frequent and difficult challeng in laboratories handling sample from pregnant women,
particularly the treatment must start as early as
possible to protect the fetus (</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="17059" xml_f="17060" txt_i="10708" txt_f="10709">7</offsets></xref><offsets xml_i="17067" xml_f="17069" txt_i="10709" txt_f="10711">, </offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="17101" xml_f="17103" txt_i="10711" txt_f="10713">18</offsets></xref><offsets xml_i="17110" xml_f="17295" txt_i="10713" txt_f="10898">). In this study,
we investigated the changes for improving the
methods of avidity testing to obtain an appropriate
serum dilution and to get actual results far from the
false negative.</offsets></p><p><offsets xml_i="17302" xml_f="17566" txt_i="10899" txt_f="11163">As it was described in method, serum of patients
were prepared in different dilutions, and were tested by various commercial kits . The study showed
that a proper index of avidity occurred at a certain
point of dilution, at which it would have a high
specificity (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="17596" xml_f="17602" txt_i="11163" txt_f="11169">Figs 1</offsets></xref><offsets xml_i="17609" xml_f="17610" txt_i="11169" txt_f="11170">-</offsets><xref ref-type="fig" rid="F8"><offsets xml_i="17640" xml_f="17645" txt_i="11170" txt_f="11175">Fig 8</offsets></xref><offsets xml_i="17652" xml_f="17748" txt_i="11175" txt_f="11271">). Some of theses commercial kits have been predicted two limiting dilutions for
avidity index (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="17780" xml_f="17782" txt_i="11271" txt_f="11273">13</offsets></xref><offsets xml_i="17789" xml_f="17791" txt_i="11273" txt_f="11275">).</offsets></p><p><offsets xml_i="17798" xml_f="18094" txt_i="11276" txt_f="11569">These kits are prior to those in which only a single sample is used, but the present study showed
that two dilutions of serum samples are not sufficient. The ranges of low avidity and borderline are
important, so different studies showed the following wide ranges for them: platelia kit &lt;40% (</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="18126" xml_f="18128" txt_i="11569" txt_f="11571">19</offsets></xref><offsets xml_i="18135" xml_f="18172" txt_i="11571" txt_f="11605">) ,
DIESSE and TESTLINE kit &lt;30% (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="18204" xml_f="18206" txt_i="11605" txt_f="11607">13</offsets></xref><offsets xml_i="18213" xml_f="18235" txt_i="11607" txt_f="11626">),Vidas kit
&lt;20 % (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="18267" xml_f="18269" txt_i="11626" txt_f="11628">13</offsets></xref><offsets xml_i="18276" xml_f="18278" txt_i="11628" txt_f="11630">, </offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="18310" xml_f="18312" txt_i="11630" txt_f="11632">15</offsets></xref><offsets xml_i="18319" xml_f="18352" txt_i="11632" txt_f="11662">), and liesenfeld study &lt;50% (</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="18384" xml_f="18386" txt_i="11662" txt_f="11664">20</offsets></xref><offsets xml_i="18393" xml_f="18460" txt_i="11664" txt_f="11731">).
It is because of performance of avidity test on a
single sample.</offsets></p><p><offsets xml_i="18467" xml_f="18654" txt_i="11732" txt_f="11919">The mesurement of IgG avidity has shown its
power in various clinical settings, especialy in
situations where timing and differentiation of primary and secoundary infections are crucial (</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="18686" xml_f="18688" txt_i="11919" txt_f="11921">19</offsets></xref><offsets xml_i="18695" xml_f="18848" txt_i="11921" txt_f="12074">).
However, by improving the method of measuring IgG avidity in mean and high concentrations,
the power of differentiation of this test may be
increased.</offsets></p><p><offsets xml_i="18855" xml_f="19151" txt_i="12075" txt_f="12371">Nowadays, several commercial kits are available for measuring of toxo IgG avidity. There
are not many available published cross-evaluations of their diagnostic performances. A high
assay modified in-house for avidity determination was observed with immunocompromised
patients and healthy adults (</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="19183" xml_f="19185" txt_i="12371" txt_f="12373">21</offsets></xref><offsets xml_i="19192" xml_f="19290" txt_i="12373" txt_f="12471">). In another
study, a poor correlation has been shown among
three commercial IgG-avidity assays (</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="19322" xml_f="19324" txt_i="12471" txt_f="12473">22</offsets></xref><offsets xml_i="19331" xml_f="19400" txt_i="12473" txt_f="12542">). The
following reports, however, have criticized important points (</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="19432" xml_f="19434" txt_i="12542" txt_f="12544">21</offsets></xref><offsets xml_i="19441" xml_f="19444" txt_i="12544" txt_f="12547">). </offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="19489" xml_f="19499" txt_i="12549" txt_f="12559">Conclusion</offsets></title><p><offsets xml_i="19510" xml_f="19811" txt_i="12560" txt_f="12861">High concenteration of Toxo IgG affects the
results of avidity. In our study, the best point of
dilution for a good avidity, in both high and borderline avidities, is marked with arrows in figures
1-8. This study revealed that improved methods
of measuring Toxo avidity IgG has got a great
importance.</offsets></p></sec></body><back><ack><p>This Study was supported by a grant from Infectious Disease and Tropical Research Center of Tabriz University of Medical Sciences, Iran. We also
wish to thank the staff working for Dr. Bonyadi’s
Laboratory. This study was also supported by Vircell Microbiology Company. There is no conflict
of interest in this study.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenum</surname><given-names>PA</given-names></name><name><surname>Stray-Pedersen</surname><given-names>B</given-names></name><name><surname>Gundersen</surname><given-names>AG</given-names></name></person-group><article-title>I improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity</article-title><source>J Clin Microbiol</source><year>1997</year><volume>35</volume><issue>8</issue><fpage>1972</fpage><lpage>1977</lpage><pub-id pub-id-type="pmid">9230365</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert-Gangneux</surname><given-names>F</given-names></name><name><surname>Darde</surname><given-names>ML</given-names></name></person-group><article-title>Epidemiology of and diagnostic strategies for toxoplasmosis</article-title><source>Clin Microbiol Rev</source><year>2012</year><volume>25</volume><issue>2</issue><fpage>264</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">22491772</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saadatnia</surname><given-names>G</given-names></name><name><surname>Golkar</surname><given-names>M</given-names></name></person-group><article-title>A review on human toxoplasmosis</article-title><source>Scand J Infect Dis</source><year>2012</year><volume>44</volume><issue>11</issue><fpage>805</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">22831461</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joynson</surname><given-names>DH</given-names></name><name><surname>Payne</surname><given-names>RA</given-names></name><name><surname>Rawal</surname><given-names>BK</given-names></name></person-group><article-title>Potential role of IgG avidity for diagnosing toxoplasmosis</article-title><source>J Clin Pathol</source><year>1990</year><volume>43</volume><issue>12</issue><fpage>1032</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">2132560</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villard</surname><given-names>O</given-names></name><name><surname>Breit</surname><given-names>L</given-names></name><name><surname>Cimon</surname><given-names>B</given-names></name><name><surname>Franck</surname><given-names>J</given-names></name><name><surname>Fricker-Hidalgo</surname><given-names>H</given-names></name><name><surname>Godineau</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies</article-title><source>Clin Vaccine Immunol</source><year>2013</year><volume>20</volume><issue>2</issue><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">23239801</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedman</surname><given-names>K</given-names></name><name><surname>Lappalainen</surname><given-names>M</given-names></name><name><surname>Seppaia</surname><given-names>I</given-names></name><name><surname>Makela</surname><given-names>O</given-names></name></person-group><article-title>Recent primary toxoplasma infection indicated by a low avidity of specific IgG</article-title><source>J Infect Dis</source><year>1989</year><volume>159</volume><issue>4</issue><fpage>736</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">2926163</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candolfi</surname><given-names>E</given-names></name><name><surname>Pastor</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>R</given-names></name><name><surname>Filisetti</surname><given-names>D</given-names></name><name><surname>Villard</surname><given-names>O</given-names></name></person-group><article-title>IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women</article-title><source>Diagn Microbiol Infect Dis</source><year>2007</year><volume>58</volume><issue>1</issue><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">17368807</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanyuksel</surname><given-names>M</given-names></name><name><surname>Guney</surname><given-names>C</given-names></name><name><surname>Araz</surname><given-names>E</given-names></name><name><surname>Saracli</surname><given-names>MA</given-names></name><name><surname>Doganci</surname><given-names>L</given-names></name></person-group><article-title>Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis</article-title><source>J Microbiol</source><year>2004</year><volume>42</volume><issue>3</issue><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">15459650</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasodhara</surname><given-names>P</given-names></name><name><surname>Ramalakshmi</surname><given-names>BA</given-names></name><name><surname>Sarma</surname><given-names>MK</given-names></name></person-group><article-title>A new approach to differentiate recent vs chronic Toxoplasma infection: avidity elisa in Toxoplasma serology</article-title><source>Indian J Med Microbiol</source><year>2001</year><volume>19</volume><issue>3</issue><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">17664818</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gay-Andrieu</surname><given-names>F</given-names></name><name><surname>Fricker-Hidalgo</surname><given-names>H</given-names></name><name><surname>Sickinger</surname><given-names>E</given-names></name><name><surname>Espern</surname><given-names>A</given-names></name><name><surname>Brenier-Pinchart</surname><given-names>MP</given-names></name><name><surname>Braun</surname><given-names>HB</given-names></name><etal></etal></person-group><article-title>Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera</article-title><source>Diagn Microbiol Infect Dis</source><year>2009</year><volume>65</volume><issue>3</issue><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">19822270</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abolghasem</surname><given-names>SP</given-names></name><name><surname>Bonyadi</surname><given-names>MR</given-names></name><name><surname>Babaloo</surname><given-names>Z</given-names></name><name><surname>Porhasan</surname><given-names>A</given-names></name><name><surname>Nagili</surname><given-names>B</given-names></name><name><surname>Gardashkhani</surname><given-names>OA</given-names></name><etal></etal></person-group><article-title>IgG avidity test for the diagnosis of acute toxoplasma gondii infection in early pregnancy</article-title><source>Iran J Immunol</source><year>2011</year><volume>8</volume><issue>4</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">22201623</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koskiniemi</surname><given-names>M</given-names></name><name><surname>Lappalainen</surname><given-names>M</given-names></name><name><surname>Hedman</surname><given-names>K</given-names></name></person-group><article-title>Toxoplasmosis needs evaluation.An overview and proposals</article-title><source>Am J Dis Child</source><year>1989</year><volume>143</volume><issue>6</issue><fpage>724</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">2658550</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>KN</given-names></name><name><surname>Szenasi</surname><given-names>Z</given-names></name><name><surname>Danka</surname><given-names>J</given-names></name><name><surname>Kucsera</surname><given-names>I</given-names></name></person-group><article-title>Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti-Toxoplasma gondii IgG avidity assays</article-title><source>Acta Parasitologica</source><year>2005</year><volume>50</volume><issue>3</issue><fpage>255</fpage><lpage>260</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Khalid</surname><given-names>N</given-names></name></person-group><article-title>Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis</article-title><source>J Med Microbiol</source><year>2007</year><volume>56</volume><issue>Pt 11</issue><fpage>1495</fpage><lpage>1499</lpage><pub-id pub-id-type="pmid">17965351</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>J</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Piedrola</surname><given-names>G</given-names></name><name><surname>del Carmen Maroto</surname><given-names>M</given-names></name></person-group><article-title>Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis</article-title><source>Clin Microbiol Infect</source><year>1997</year><volume>3</volume><issue>6</issue><fpage>658</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">11864209</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefevre-Pettazzoni</surname><given-names>M</given-names></name><name><surname>Le Cam</surname><given-names>S</given-names></name><name><surname>Wallon</surname><given-names>M</given-names></name><name><surname>Peyron</surname><given-names>F</given-names></name></person-group><article-title>Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2006</year><volume>25</volume><issue>11</issue><fpage>687</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">17024503</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meek</surname><given-names>B</given-names></name><name><surname>van Gool</surname><given-names>T</given-names></name><name><surname>Gilis</surname><given-names>H</given-names></name><name><surname>Peek</surname><given-names>R</given-names></name></person-group><article-title>Dissecting the IgM antibody response during the acute and latent phase of toxoplasmosis</article-title><source>Diagn Microbiol Infect Dis</source><year>2001</year><volume>41</volume><issue>3</issue><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">11750166</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gras</surname><given-names>L</given-names></name><name><surname>Wallon</surname><given-names>M</given-names></name><name><surname>Pollak</surname><given-names>A</given-names></name><name><surname>Cortina-Borja</surname><given-names>M</given-names></name><name><surname>Evengard</surname><given-names>B</given-names></name><name><surname>Hayde</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.a cohort study in 13 European centres</article-title><source>Acta Paediatr</source><year>2005</year><volume>94</volume><issue>12</issue><fpage>1721</fpage><lpage>1731</lpage><pub-id pub-id-type="pmid">16421031</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachaud</surname><given-names>L</given-names></name><name><surname>Calas</surname><given-names>O</given-names></name><name><surname>Picot</surname><given-names>MC</given-names></name><name><surname>Albaba</surname><given-names>S</given-names></name><name><surname>Bourgeois</surname><given-names>N</given-names></name><name><surname>Pratlong</surname><given-names>F</given-names></name></person-group><article-title>Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination</article-title><source>Diagn Microbiol Infect Dis</source><year>2009</year><volume>64</volume><issue>3</issue><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">19395217</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liesenfeld</surname><given-names>O</given-names></name><name><surname>Montoya</surname><given-names>JG</given-names></name><name><surname>Kinney</surname><given-names>S</given-names></name><name><surname>Press</surname><given-names>C</given-names></name><name><surname>Remington</surname><given-names>JS</given-names></name></person-group><article-title>Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory</article-title><source>J Infect Dis</source><year>2001</year><volume>183</volume><issue>8</issue><fpage>1248</fpage><lpage>1253</lpage><pub-id pub-id-type="pmid">11262207</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname><given-names>M</given-names></name><name><surname>Hedman</surname><given-names>K</given-names></name></person-group><article-title>Serodiagnosis of toxoplasmosis.The impact of measurement of IgG avidity</article-title><source>Ann Ist Super Sanita</source><year>2004</year><volume>40</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">15269456</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barberi</surname><given-names>A</given-names></name><name><surname>Gistri</surname><given-names>A</given-names></name><name><surname>Cappelletti</surname><given-names>F</given-names></name><name><surname>Giordano</surname><given-names>I</given-names></name></person-group><article-title>Diagnostic value of IgG avidity in Toxoplasma infection: comparison of 3 commercial kits</article-title><source>J Infect Dis</source><year>2001</year><volume>184</volume><issue>7</issue><fpage>944</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">11550130</pub-id></element-citation></ref></ref-list></back></article>